Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling

ConferenceNULISAeMTBR-TauBD-pTau217Positive

AI Analysis

Summary

Alamar Biosciences will feature NULISA data in more than 140 scientific presentations at AAIC 2026, highlighting advances in blood-based Alzheimer's biomarker profiling including eMTBR-Tau and BD-pTau217 research data for disease detection and staging.

Importance:5/10

Sentiment:

0.50

AAIC 2026blood-based biomarkersAlzheimer's diseasescientific presentationsdiagnosticresearch data

Related Companies

$ALMR

Read the original article

Published by GlobeNewswire Clinical Studies on July 10, 2026 10:11 AM

Read Original